JPRN-UMIN000022568已完成未知
Special Drug Use Results Survey of Targretin capsules 75-mg in patients with Cutaneous T-cell Lymphomas - Targretin Special Drug Use Surveillance (CTCL)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •No criteria
研究者
相似试验
招募中
不适用
Special Drug Use-results Survey of Targretin Capsules combined with photo(chemo)therapyCutaneous T-cell lymphomaJPRN-jRCT2031210625pharmacovigilance departmant70
进行中（未招募）
不适用
Special drug-use survey of Tarlige tablet (evaluation of safety in long-term use)JPRN-jRCT2031200212Matsuoka Yomei900
招募中
不适用
Special drug-use survey of Tarlige (central neuropathic pain)Central neuropathic painJPRN-jRCT2031220132Matsuoka for Yomei400
已完成
Unknown
Special drug-use survey of Tarlige (evaluation of the efficacy in patients with peripheral neuropathic pain)JPRN-jRCT1080224913DAIICHI SANKYO CO., LTD1,890
已完成
Unknown
Special Drug Use-Results Survey of Onoacttachyarrhythmia, atrial fibrillation/atrial flutter in patients with cardiac dysfunctionJPRN-jRCT1080222572ONO PHARMACEUTICAL CO., LTD.800